Abstract：OBJECTIVE: To assess the changes of neurobehavioral function in a neonatal mouse model of excitotoxic brain damage. METHODS: Fifty-five 5-day-old ICR neonatal mice were randomly assigned to three groups: blank (no intravenous) control (n=20), saline control (n=20) and excitotoxic brain damage model (ibotenic acid treatment, n=15). Behavioral function was evaluated by the surface righting reflex test (postnatal days 6-10), the swimming test (postnatal days 8-12) and the Y-maze discrimination learning test (postnatal days 33-34). RESULTS: Righting time in the surface righting reflex test in the ibotenic acid treatment group on postnatal days 6-10 was more prolonged than that in the two control groups (P<0.05). Swimming test scores in the ibotenic acid treatment group were significantly lower than those in the two control groups (P<0.05). In the Y-maze discrimination learning test, the mice from the ibotenic acid treatment group performed significantly worse than two control groups, presenting with increased learning times (19.79±2.42 vs 16.29±2.48 or 16.30±2.37; P<0.05) and achieving a lower correct percentage (86.7% vs 96.5% or 95.0%) (P<0.05). CONCLUSIONS:The developmental reflexes and learning and memory functions were impaired in neonatal mice following excitotoxic brain damage. Behavioral testing is useful in the evaluation of early developmental reflexes and long-term neurobehavioral outcome in neonatal mice with excitotoxic brain damage.［Chin J Contemp Pediatr, 2009, 11 (3):191-193］
［1］Inage YW, Itoh M, Takashima S. Correlation between cerebrovascular maturity and periventricular leukomalacia［J］.Pediatr Neurol, 2000, 22 (3):204-208.
［3］Rogido M, Husson I, Bonnier C, Lallemand MC, Mérienne C, Gregory GA,et al. Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain［J］. Brain Res Dev Brain Res, 2003, 140(2):287-297.
［4］Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions［J］. Neuropathol Exp Neurol, 1995, 54(3):358-370.
［5］Kihara T, Surjono TW, Sakamoto M, Matsuo T, Yasuda Y, Tanimura T.Effects of prenatal rubratoxin-B exposure on behaviors of mouse offspring［J］.Toxicol Sci, 2001, 61(2):368-373.
［6］Xu XH, Zhao TQ. Effects of puerarin on D-galactose-induced memory deficits in mice ［J］.Acta Pharmacol Sin, 2002, 23(7):587-590.
［7］Roohey T, Raju TN, Moustogiannis AN. Animal models for the study of perinatal hypoxic-ischemic encephalopathy: a critical analysis［J］. Early Hum Dev, 1997, 47 (2):115-146.
［8］Ikeda T, Mishima K, Yoshikawa T, Iwasaki K, Fujiwara M, Xia YX, et al.Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats［J］. Behav Brain Res, 2001, 118(1):17-25.
［11］Loftis JM, Janowsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications［J］. Pharmacol Ther, 2003, 97(1):55-85.
［12］Vorhee CV. Behavioral and functional ontogeny: biomarkers of neurotoxicity［M］.//Chang LW. Principles of Neurotoxicology. New York:Marcel Dekker, Inc, 1994, 241-250.
